New: Instantly spot drawdowns, dips, insider moves, and breakout themes across Maps and Screener.

Learn More

Guggenheim Raises Price Target for Bruker Corporation (BRKR)

By Muhammad Ali Khalid | January 30, 2026, 2:31 PM

Bruker Corporation (NASDAQ:BRKR) is one of the 12 best Medical Devices stocks to invest in according to Hedge Funds.

On January 26, Guggenheim analyst Subbu Nambi reiterated her Buy rating on Bruker Corporation (NASDAQ:BRKR). She revised her price target from $53 to $58, which leads to an upside potential of almost 25%.

Copyright: dolgachov / 123RF Stock Photo

Nambi’s target price adjustment is part of Guggenheim’s revisions to its forecasts and targets for many of the stocks within the Diagnostics and Life Sciences Tools category. These changes are based on recent updates and some preliminary results for the fourth quarter.

Earlier, on January 7, Daniel Brennan of TD Cowen reaffirmed his Hold rating on Bruker Corporation (NASDAQ:BRKR), and simultaneously revised his price target from $42 to $53.

Brennan’s rating was also a part of his firm’s broader adjustments across the Life Science Tools segment, based on the outlook for the fourth quarter. The analyst noted that many companies have “already soft guided” 2026, which keeps him optimistic for the coming year.

Bruker Corporation (NASDAQ:BRKR) is involved in the development and distribution of high-performance scientific instruments and analytical and diagnostic solutions. Their offerings are useful in pharmaceutical and molecular research, biotechnology, and materials analysis. It functions through 4 distinct segments, i.e., BSI BioSpin, BSI Nano, BSI CALID, and Bruker Energy & Supercon Technologies (BEST).

While we acknowledge the potential of BRKR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 15 Most Promising Mid-Cap Healthcare Stocks Under $50 and 11 Most Promising Small-Cap Industrial Stocks Under $50.

Disclosure: None. This article is originally published at Insider Monkey.

Mentioned In This Article

Latest News